Table 2.

Adjusted predictors (relative risk) of treatment access in relation to screening results.^a

	Total	Clinical/history-taking detection	Screening yield	Screen negative
Men	REF	REF	REF	REF
Women	1.72 [1.57, 1.88]	2.04 [1.80, 2.31]	2.05 [1.53, 2.75]	2.02 [1.52, 2.70]
White	REF	REF	REF	REF
Indigenous	1.03 [0.95, 1.12]	1.03 [0.92, 1.15]	1.29 [1.05, 1.60]	1.09 [0.90, 1.34]
Black	0.41 [0.34, 0.49]	0.41 [0.32, 0.52]	0.27 [0.16, 0.45]	0.35 [0.24, 0.53]
Other	0.55 [0.48, 0.64]	0.43 [0.34, 0.54]	0.62 [0.43, 0.88]	0.62 [0.46, 0.85]
Atlantic	REF	REF	REF	REF
Quebec	0.64 [0.57, 0.72]	0.49 [0.41, 0.58]	0.52 [0.39, 0.70]	1.07 [0.77, 1.50]
Ontario	1.35 [1.22, 1.51]	1.30 [1.13, 1.50]	1.21 [0.90, 1.63]	2.22 [1.58, 3.12]
Prairie	0.89 [0.80, 0.99]	0.72 [0.62, 0.83]	0.83 [0.63, 1.11]	1.72 [1.24, 2.39]
Pacific	0.55 [0.47, 0.65]	0.54 [0.44, 0.67]	0.43 [0.28, 0.68]	0.79 [0.50, 1.26]
18-24	REF	REF	REF	REF
25-39	1.05 [0.96, 1.14]	1.09 [0.96, 1.23]	1.07 [0.85, 1.34]	1.02 [0.83, 1.26]
40-54	1.04 [0.94, 1.15]	1.06 [0.92, 1.22]	1.10 [0.85, 1.41]	1.01 [0.79, 1.29]
55+	0.92 [0.80, 1.06]	0.77 [0.61, 0.95]	0.88 [0.61, 1.27]	1.08 [0.80, 1.46]

^aAdjusted for all variables shown in the table and for the length of follow-up time. Models are fit separately for each screening result category, where individuals identified at prior steps are excluded when fitting the model. Bolded figures represent statistically significant findings at an alpha of .05.